-
1
-
-
44849129542
-
Latency associated peptide has in vitro and in vivo immune effects independent of TGF-beta1
-
Ali NA, Gaughan AA, Orosz CG, Baran CP, McMaken S, Wang Y, Eubank TD, Hunter M, Lichtenberger FJ, Flavahan NA, Lawler J, Marsh CB (2008) Latency associated peptide has in vitro and in vivo immune effects independent of TGF-beta1. PLoS ONE 3:e1914
-
(2008)
PLoS ONE
, vol.3
-
-
Ali, N.A.1
Gaughan, A.A.2
Orosz, C.G.3
Baran, C.P.4
McMaken, S.5
Wang, Y.6
Eubank, T.D.7
Hunter, M.8
Lichtenberger, F.J.9
Flavahan, N.A.10
Lawler, J.11
Marsh, C.B.12
-
2
-
-
0037204990
-
Signal transduction by the TGF-beta superfamily
-
Attisano L, Wrana JL (2002) Signal transduction by the TGF-beta superfamily. Science 296:1646-1647
-
(2002)
Science
, vol.296
, pp. 1646-1647
-
-
Attisano, L.1
Wrana, J.L.2
-
3
-
-
58949085659
-
A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice
-
Chen Y, Wang X, Weng D, Tian L, Lv L, Tao S, Chen J (2009) A TSP-1 synthetic peptide inhibits bleomycin-induced lung fibrosis in mice. Exp Toxicol Pathol 61:59-65
-
(2009)
Exp Toxicol Pathol
, vol.61
, pp. 59-65
-
-
Chen, Y.1
Wang, X.2
Weng, D.3
Tian, L.4
Lv, L.5
Tao, S.6
Chen, J.7
-
4
-
-
0042425009
-
Antisense oligonucleotides against thrombospondin-1 inhibit activation of TGF-beta in fibrotic renal disease in the rat in vivo
-
Daniel C, Takabatake Y, Mizui M, Isaka Y, Kawashi H, Rupprecht H, Imai E, Hugo C (2003) Antisense oligonucleotides against thrombospondin-1 inhibit activation of tgf-beta in fibrotic renal disease in the rat in vivo. Am J Pathol 163:1185-1192 (Pubitemid 37040154)
-
(2003)
American Journal of Pathology
, vol.163
, Issue.3
, pp. 1185-1192
-
-
Daniel, C.1
Takabatake, Y.2
Mizui, M.3
Isaka, Y.4
Kawashi, H.5
Rupprecht, H.6
Imai, E.7
Hugo, C.8
-
5
-
-
1642439096
-
Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo
-
DOI 10.1111/j.1523-1755.2004.00395.x
-
Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, Murphy-Ullrich JE, Hugo C (2004) Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int 65:459-468 (Pubitemid 38130640)
-
(2004)
Kidney International
, vol.65
, Issue.2
, pp. 459-468
-
-
Daniel, C.1
Wiede, J.2
Krutzsch, H.C.3
Ribeiro, S.M.F.4
Roberts, D.D.5
Murphy-Ullrich, J.E.6
Hugo, C.7
-
6
-
-
79952644384
-
Thrombospondin-1 deficientmice are not protected from bleomycin-induced pulmonary fibrosis
-
EzzieME, Piper MG, Montague C, Newland CA, Opalek JM, Baran C, Ali N, Brigstock D, Lawler J, Marsh CB (2010) Thrombospondin-1 deficientmice are not protected from bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol
-
(2010)
Am J Respir Cell Mol Biol
-
-
Ezzie, M.E.1
Piper, M.G.2
Montague, C.3
Newland, C.A.4
Opalek, J.M.5
Baran, C.6
Ali, N.7
Brigstock, D.8
Lawler, J.9
Marsh, C.B.10
-
7
-
-
0031685620
-
TGF-beta signal transduction
-
Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67:753-791
-
(1998)
Annu Rev Biochem
, vol.67
, pp. 753-791
-
-
Massague, J.1
-
8
-
-
0033524949
-
The integrin alphavbeta6 binds and activates latent TGFbeta1: A mechanism for regulating pulmonary inflammation and fibrosis
-
DOI 10.1016/S0092-8674(00)80545-0
-
Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D (1999) The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319-328 (Pubitemid 29077586)
-
(1999)
Cell
, vol.96
, Issue.3
, pp. 319-328
-
-
Munger, J.S.1
Huang, X.2
Kawakatsu, H.3
Griffiths, M.J.D.4
Dalton, S.L.5
Wu, J.6
Pittet, J.-F.7
Kaminski, N.8
Garat, C.9
Matthay, M.A.10
Rifkin, D.B.11
Sheppard, D.12
-
9
-
-
66649105474
-
Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxelgemcitabine regimen
-
Papadaki C, Mavroudis D, Trypaki M, Koutsopoulos A, Stathopoulos E, Hatzidaki D, Tsakalaki E, Georgoulias V, Souglakos J (2009) Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxelgemcitabine regimen. Clin Cancer Res 15:3827-3833
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3827-3833
-
-
Papadaki, C.1
Mavroudis, D.2
Trypaki, M.3
Koutsopoulos, A.4
Stathopoulos, E.5
Hatzidaki, D.6
Tsakalaki, E.7
Georgoulias, V.8
Souglakos, J.9
-
10
-
-
0033532054
-
The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta
-
Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274:13586-13593
-
(1999)
J Biol Chem
, vol.274
, pp. 13586-13593
-
-
Ribeiro, S.M.1
Poczatek, M.2
Schultz-Cherry, S.3
Villain, M.4
Murphy-Ullrich, J.E.5
-
11
-
-
0027305971
-
Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism
-
Schultz-Cherry S, Murphy-Ullrich JE (1993) Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 122:923-932 (Pubitemid 23241101)
-
(1993)
Journal of Cell Biology
, vol.122
, Issue.4
, pp. 923-932
-
-
Schultz-Cherry, S.1
Murphy-Ullrich, J.E.2
-
12
-
-
0036221929
-
Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer
-
DOI 10.1016/S0169-5002(01)00470-6, PII S0169500201004706
-
Yamaguchi M, Sugio K, Ondo K, Yano T, Sugimachi K (2002) Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer. Lung Cancer 36:143-150 (Pubitemid 34296556)
-
(2002)
Lung Cancer
, vol.36
, Issue.2
, pp. 143-150
-
-
Yamaguchi, M.1
Sugio, K.2
Ondo, K.3
Yano, T.4
Sugimachi, K.5
|